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mia have significant effects on cardiac fibrosis and arterial wallHyperphosphatemia aggravates cardiac fibrosis and microvas-
thickening. Such abnormalities of cardiac architecture may becular disease in experimental uremia.
relevant for the increased cardiac risk in hyperphosphatemicBackground. Hyperphosphatemia is a known predictor of
uremic patients.cardiovascular death and specifically of cardiac death in hemo-
dialysis patients. The pathomechanisms involved have not been
completely clarified. While a number of observations suggest
an important role of hyperphosphatemia and positive calcium Following the observation of Block and Port [1] thatbalance on atherosclerosis and calcification of the coronary
predialytic concentrations of phosphate 6.5 mg/dL areconduit arteries, independent effects on postcoronary mi-
associated with significantly greater overall mortalitycrovessels and on cardiac fibrosis have not been excluded.
Methods. Male Sprague-Dawley rats were sham operated and, specifically, mortality from cardiac causes [2], con-
(N  14) or subtotally nephrectomized (SNX, N  17) and siderable interest has focused on the mechanisms through
subsequently placed on low phosphorus (0.08% w/w) and high
which the effect of serum phosphate is mediated. In viewphosphorus (1.2% w/w) diet under pair-feeding conditions.
of the great propensity of coronary [3–5] and carotidAfter 8 weeks, serum chemistry and inhibitory parathyroid
hormone (iPTH) were measured, and the hearts were har- plaques to calcify, increased calcification of coronary
vested using perfusion fixation. Arteriolar thickness and vol- plaques is certainly one likely mechanism. Nevertheless,
ume density of the interstitium (excluding vessels) were quanti- the adverse effect of phosphate on cardiovascular struc-tated using stereologic techniques.
tures and functions may be more complex. For instance,Results. In SNX animals with moderate renal failure serum
exposure to high phosphate concentrations alters thephosphorus concentrations were higher than in sham-operated
controls on low phosphorus diet (1.7 0.37 mmol/L) and were phenotype of vascular smooth muscle cells [6, 7]. It has
significantly higher in SNX  high phosphorus diet (2.33  also been found that high phosphate concentrations are
0.23 mmol/L) compared to SNX low phosphorus diet (1.95
associated with hemodynamic abnormalities in dialysis0.32 mmol/L; P  0.05). In sham-operated controls, dietary
patients, presumably resulting from stiffening of the cen-phosphorus content had no effect on cardiac morphologic indi-
ces. In contrast, in SNX  high phosphorus diet the index tral arteries unrelated to atherosclerosis [8].
of interstitial cardiac fibrosis was significantly higher (3.22  In dialyzed patients, cardiac mortality is excessive rela-
0.44%) than in SNX  low phosphorus (2.75  0.46%) or in tive to the background population [9, 10]. The majoritysham-operated controls (2.5  0.05% on high phosphorus and
of dialyzed patients do not die from myocardial in-2.4  0.89 on low phosphorus, respectively). In SNX  high
farction, but as a result of sudden death. We reasonedphosphorus (14.0 9.0 m), but not in SNX low phosphorus
(9.2  4.5 m), arterial wall thickness was significantly higher that in addition to the high prevalence and high rate of
compared to sham-operated controls (10.2 5.1 on high phos- progression of atherogenesis, cardiac function may also
phorus and 9.8  5.0 m on low phosphorus, respectively).
be adversely affected by noncoronary mechanisms [11].The data were confirmed in an independent repeat experiment.
This reasoning is based on the observation that bloodConclusion. High dietary phosphorus and hyperphosphate-
pressure–independent fibrosis [12] and thickening of ar-
teries [13] have been documented in the heart of uremicKey words: hyperphosphatemia, cardiovascular death, uremia, cardiac
animals and patients, respectively.fibrosis, capillary supply, uremic cardiomyopathy, arterial wall thick-
ness. The present study used a model of moderate experi-
mental renal failure and was designed to test the hypoth-Received for publication July 24, 2002
esis that differences in dietary phosphorus and the con-and in revised form October 7, 2002
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METHODS Perfusion fixation and tissue sampling
Eight weeks after the second operation, the experi-Animals, diet, pair-feeding protocol, food consumption
ment was terminated by retrograde perfusion fixation atMale Sprague-Dawley rats (200 g) (Ivanovas Co., Kiss-
a controlled pressure of 120 mm Hg. The abdominallegg, Germany) were housed in single cages at constant
aorta was catheterized under ketamine/diazepam anes-temperature (20C) and humidity (25%). From the be-
thesia (doses as above), and blood samples were takenginning of the experiment, the animals received a high
for determination of serum chemistry. The viscera wereprotein (40%), low salt (0.5% NaCl) diet (ssniff Spezial-
rinsed with 10% dextran solution containing 0.5 g/L pro-dia¨ten GmbH, Bogst, Germany). The low phosphorus
caine hydrochloride for 2 minutes. Ten seconds afterdiet contained 0.08% phosphorus (S8045 E030) and the
starting the aortic perfusion, the vena cava was incisedphosphorus-rich diet 1.2% (S8045 E031). After 3 days
to drain the blood. After dextran infusion, the vascularof adaptation, the animals were randomly allocated to
system was perfused with 0.2 mol/L phosphate buffermoderate partial nephrectomy (SNX) or sham operation
containing 3% glutaraldehyde for 12 minutes. After the(sham). A modified pair-feeding protocol was used (i.e.,
perfusion, the heart and the aorta of each animal weresham-operated rats with low phosphorus diet received
taken out and the heart and left ventricular weight werethe amount of food that was consumed by the sham
determined. Tissue samples and sections were obtained
group with high phosphorus the day before). The same
and stained according to the orientator method [17].
procedure was applied for the two SNX groups. The
Uniformly random sampling of the myocardium was
animals were followed up for 8 weeks. achieved by preparing a set of equidistant slices of the left
ventricle and the interventricular septum with a randomPartial renal ablation by surgical subtotal
start. Two slices were selected by area-weighted sam-nephrectomy (SNX)
pling and processed accordingly. Eight pieces of the left
First, in SNX animals, the right kidney was removed ventricular muscle, including the septum, were prepared
under ketamine/diazepam anesthesia (100 mg/kg or 2.5 and afterwards embedded in Epon-Araldite. Semithin
g/kg, respectively) and the weight of the kidney was sections (0.8 m) were stained with methylene-blue and
determined. Control animals were sham operated (i.e., basic fuchsin and examined by light microscopy with oil
the right kidney was decapsulated). Special care was immersion and phase contrast at a magnification of
taken to avoid damage to the adrenals. Seven days later, 1000:1 [16]. A 1 mm thick piece of the aorta thoracica
in the SNX group, the cortex of the meanwhile hypertro- descendens was cut perpendicular to the vessel axis and
phied left kidney was partially resected, removing a embedded and sectioned as described above.
quantity corresponding to 2/3 of the weight of the pre-
viously resected right kidney. Again, sham operation of Quantitative morphologic investigations
control animals was performed by decapsulating the left All investigations were performed in a blinded manner
kidney. This standardized procedure of a two-step, (i.e., the observer was unaware of the study group to
weight-controlled surgical resection of renal cortex re- which the animal belonged). Stereologic analysis was
sulted in a very moderate and stable degree of renal performed on eight random samples of differently orien-
failure with no or only minor increase in systolic blood tated sections of the left ventricular myocardium per
pressure. Using the above-described procedure of mod- animal, according to the orientator method [17]. Volume
erate two-step subtotal nephrectomy the nephron num- density (VV) of capillaries, interstitial tissue, and myo-
ber per kidney is reduced from approximately 30,000 cytes was obtained using the point counting method ac-
to 15,000. The model had been used in several former cording to the equation PP  VV, where PP is point den-
experiments and the course of renal failure, as well as sity. Reference volume was the total myocardial tissue
the development of cardiovascular and renal alterations (exclusive of noncapillary vessels, that is, arterioles and
under standard diet, are very well documented [13–16]. veins). Vascular geometry of intramyocardial arteries
(i.e., wall thickness, lumen diameter, media and lumen
Experimental protocol area) was analyzed using a semiautomatic image analysis
After 3 days of adaptation the animals were randomly system (Videoplan, Kontron Co., Eching, Germany) as
allocated to the following experimental groups: (1) sham- described in detail [16].
operated controls  low phosphorus (N  6); (2) sham-
Statisticsoperated controls  high phosphorus (N  5); (3) SNX
rats  low phosphorus (N  8); and (4) SNX rats  All data are expressed as mean  standard deviation.
high phosphorus (N  9). After testing for normality of distribution one-way analy-
At the end of the experiment these animals were placed sis of variance (ANOVA) was performed, followed by the
least significant difference test to assess the differencesinto metabolic cages to collect 24-hour urine samples.
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Table 1. Animal data
Sham operation Subtotal nephrectomy (SNX)
Low phosphorus High phosphorus Low phosphorus High phosphorus
diet (N  6) diet (N  5) diet (N  8) diet (N  9) ANOVA
Final body weight g 33234.4a 36664.5b 27424.8c 39530.1b P  0.001
Food consumption g/day 15.81.6 15.81.5 14.72.0 16.82.3 NS
Weight of left ventricle mg 76074 792121a 70092 917130b,c P  0.05
Serum creatinine mg/dL 0.680.07 0.680.09a 0.960.09 0.970.08c P  0.05
Serum phosphorous mmol/L 1.70.37 2.40.32a 1.950.32 2.330.23b,c P  0.05
Serum calcium mmol/L 2.630.13 2.560.16a 2.740.07 2.450.12b,c P  0.05
iPTH pmol/L 8.573.15 10351.3a,c 3.381.67 11478.00b,c P  0.05
iPTH is inhibitory parathyroid hormone.
aP  0.05 vs SNX  high phosphorus
bP  0.05 vs SNX  low phosphorus
cP  0.05 vs sham-operated  low phosphorus
between the groups. Results were considered significant Interstitital volume density
when the probability of error (P) was less than 0.05. The volume density of nonvascular interstitial tissue
was not affected by dietary phosphorus content in sham-
operated animals. In SNX animals on low phosphorusRESULTS
diet, it was not significantly different from sham-oper-
Animal data ated animals. In contrast, total volume density of the
Despite comparable body weight at the beginning of interstitium was significantly higher in SNX high phos-
the experiment, pair-feeding, and comparable daily food phorus diet (Fig. 2). As documented in Table 2, the
consumption. Final body weight was significantly lower in increase in nonvascular interstitial tissue did not concern
SNX low phosphorus than in all other groups (Table 1). fibrocytes, but exclusively fibrous tissue.
Left ventricular weight after perfusion fixation was sig-
nificantly higher in SNX high phosphorus compared to
DISCUSSIONSNX low phosphorus; this was not the case, however, if
left ventricular weight was factored for body weight. In the ongoing discussion on the pathomechanisms
Serum creatinine was significantly higher in both SNX underlying the deleterious action of hyperphosphatemia
groups than in sham-operated animals. Animals on high on cardiac mortality in dialysis patients, the present study
phosphorus diet had higher fasting serum phosphorus adds one further aspect by documenting that dietary
concentrations, both in the group of sham-operated and phosphorus intake and hyperphosphatemia contribute
of SNX animals. High phosphorus diet caused a signifi- to abnormalities of the postcoronary arterial vessels in
cant increase of inhibitory parathyroid hormone (iPTH) the myocardium and to interstitial fibrosis. If the data
both in the sham-operated and SNX groups. It also in SNX rats can be extrapolated to humans, they would
caused somewhat lower serum calcium levels. indicate the existence of more severe microvascular dis-
ease and cardiac fibrosis in hyperphosphatemic uremic
Arterial morphology patients. These vascular abnormalities would presum-
ably interfere with the vasodilatory reserve and withThe luminal area of intramyocardial arteries was sig-
nificantly reduced in both SNX groups (Fig. 1 C and D) ischemia tolerance. The pronounced interstitial fibrosis
could reduce left ventricular compliance and increasecompared to the sham-operated animals (Fig. 1 A and
B) (Table 2). The arterial wall thickness and wall to arrhythmogenicity [18, 19]. The epicardial arteries in
these animals were unremarkable (data not given), butlumen ratio, as well as the relative wall area, were not
significantly different between the sham-operated ani- this observation is not very informative because rat does
not develop classical coronary atherosclerosis [20].mals on low and high phosphorus diet. These parameters
were significantly higher, however, in SNX high phos- In order to exclude artifacts from differing food in-
takes, great care was taken in the present experiment tophorus diet compared to SNX  low phosphorus and
sham-operated animals, respectively. In contrast, in SNX guarantee identical intakes of low and high phosphorus
diet, respectively, using a pair-feeding protocol. Theanimals on low phosphorus diet, the values were not
significantly different from sham-operated control ani- comparison of daily food consumption document that
this goal has been achieved. The final body weight, how-mals. Figure 1 shows representative examples of intra-
myocardial arteries of sham-operated and SNX animals ever, differed between SNX on low phosphorus diet and
the other groups. As anticipated, high phosphorus dieton high and low phosphorus diet, respectively.
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Fig. 1. Representative examples of intramyocardial arteries. (A ) Sham-operated rats  low phosphorus diet. (B ) Sham-operated rats  high
phosphorus diet. (C ) Subtotal nephrectory (SNX)  low phosphorus diet. (D ) SNX  high phosphorus diet. Arteriolar wall thickness is increased
in SNX on high phosphorus diet (D) compared to all other groups. Semithin sections, methylene-blue, and basic fuchsin stain.
Table 2. Morphologic investigations
Sham operation Subtotal nephrectomy (SNX)
Low phosphorus High phosphorus Low phosphorus High phosphorus
diet (N  6) diet (N  5) diet (N  8) diet (N  9) ANOVA
Lumen diameter of intramyocardial
arteries lm 7144.4 64.834.1 52.531.0a 53.538.6a P  0.05
Wall thickness of intramyocardial
arteries lm 9.85.0 10.25.1 9.24.5a 14.09.0a,b P  0.05
Wall-to-lumen ratio of intramyocardial
arteries lm/lm 0.170.17 0.190.14c 0.200.09a 0.280.14a,b P  0.05
Volume density of interstitial fibrous
tissue % 1.50.55 1.80.45 1.880.35 2.330.50a P  0.05
Volume density of interstitial cells % 1.00.0 0.60.55 0.880.35 0.890.33 NS
a P  0.05 vs. sham-operated  low phosphorus; bP  0.05 vs. SNX  low phosphorus; cP  0.05 vs. SNX  high phosphorus
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lated protein receptors [22], but a causal role of PTH is
less likely because the increase in iPTH concentrations
was comparable in the sham operated controls and the
rats with moderate renal failure in this short-term experi-
ment. We acknowledge that in the past our laboratory
showed that PTH affected arterioles and the cardiac
interstitium [23, 24]. Despite higher serum phosphorus
and iPTH levels, changes in arterioles and interstitium
were not observed in sham-operated animals on high
phosphorus diet. Whether the uremic milieu is required
to “sensitize” the heart to the effects of PTH needs
further study.
With respect to cardiac fibrosis, several comments are
appropriate. The increment in the volume fraction of
Fig. 2. Volume density of total cardiac non-interstitial tissue (fibers the nonvascular interstitium concerned exclusively fi-
and cells). Subtotal nephrectomy (SNX)  high phosphorus (P) diets bers, but not fibrocytes. Higher density of fibrous tissue
show a significantly higher amount of nonvascular interstitium than
in SNX animals on high phosphorus compared to lowall other groups. *P  0.05 vs. both sham-operated groups; P  0.05
vs. SNX  low phosphorus diet. phosphorus diet would be consistent with either in-
creased fibrogenesis or diminished breakdown of fibrous
tissue. There is no information available whether colla-
gen synthesis or collagenase activity are influenced by
was associated with higher serum phosphorus concentra- dietary phosphorus or serum phosphorus concentration.
tions in sham-operated and SNX rats. Hyperphosphate- Although the finding was not quantitated, inspection of
mia was associated with slightly, but significantly, lower the slides showed that cardiomyocyte diameter and
serum calcium concentrations and, as also anticipated, cross-sectional areas were not significantly affected by
with higher iPTH concentrations. There was no signifi- the phosphorus content of the diet.
cant difference of iPTH concentrations on high phospho- Taken together the data indicate that changes of post-
rus diet between sham-operated and SNX animals, but coronary microvessels and of cardiac fibrous tissue con-
we emphasize that we deliberately induced only moder- tent have to be taken into consideration when one evalu-
ate renal failure (as shown by the very modest increase ates the deleterious effects of hyperphosphatemia on the
of serum creatinine and serum urea concentrations) in cardiac risk of dialysis patients [1, 5, 9]. If the results of
order to exclude numerous other confounding factors the present animal experiment can be extrapolated to
associated with end-stage renal failure, such as anemia humans, the effects of hyperphosphatemia go well be-
and metabolic acidosis. Because the number of animals yond calcification of coronary arteries [3–5] and large
was limited and because we thought that the findings central elastic arteries [8]. It is possible, but not proven,
were important, the observation was fully confirmed on that such postcoronary cardiac abnormalities further ag-
a qualitative level in a second independent experiment gravate the cardiac risk.
using exactly the same study design (data not given).
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